Clinical Trials on Chronic Obstructive Pulmonary Disease, COPD

Total 47913 results

University College, London
University of Cambridge; National Institute for Health Research, United Kingdom and other collaborators

Unknown

Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD).

United Kingdom
Reham Mohammed Elmorshedy

Completed

Ventilator Asynchrony as a Predictor of Weaning Failure

Chronic Obstructive Pulmonary Disease(COPD)

Egypt
AstraZeneca

Completed

Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069

Chronic Obstructive Pulmonary Disease (COPD).

United Kingdom
Virginia Commonwealth University
Fisher and Paykel Healthcare

Completed

The Effect of Humidification on Mucus Rheology

Chronic Obstructive Pulmonary Disease(COPD)

United States
Beaumont Hospital
Aerogen

Completed

Effectiveness of Vibrating Mesh Versus Small Volume Nebuliser in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation Acute

Ireland
Medtronic BRC

Unknown

Chronic Obstructive Pulmonary Disease (COPD) Monitoring (COPD)

COPD | COPD Exacerbation
Chiesi Farmaceutici S.p.A.

Completed

Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD (CARSAF)

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
Bezmialem Vakif University

Completed

The Effects of Creative Dance Based Exercise Training on Respiratory, Balance and Cognitive Functions, Respiratory and Peripheral Muscle Strength and Functional Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD)

COPD

Turkey
Sunovion Respiratory Development Inc.

Completed

Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). (GOLDEN7)

COPD

United Kingdom
University of Southern Denmark
Odense University Hospital; Sygekassernes Helsefond; Danish Nurses Organisation

Completed

Randomised Trial of Telehealth Consultations for Nursing Care of Chronic Obstructive Pulmonary Disease (COPD) Patients

COPD

Denmark
Novartis

Completed

Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States
PharmaEngine

Unknown

Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

COPD

Taiwan
Daewoong Pharmaceutical Co. LTD.

Completed

Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

COPD

Korea, Republic of
Novartis Pharmaceuticals

Completed

Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BRIGHT)

COPD

Germany, Spain
Cimera
Hospital Clinic of Barcelona; Hospital Son Espases; Germans Trias i Pujol Hospital and other collaborators

Completed

Study of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations In Spain (ECOS)

COPD

Spain
Sunovion

Completed

A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States
Chiesi Farmaceutici S.p.A.

Completed

Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects

Chronic Obstructive Pulmonary Disease (COPD) | COPD

United Kingdom
Elpen Pharmaceutical Co. Inc.

Completed

A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination (RETRIEVE)

COPD | COPD Exacerbation

Greece
Rigshospitalet, Denmark

Unknown

Muscle Function After Lung Transplantation in Patients With Chronic Obstructive Pulmonary Disease (COPD) (COPD)

COPD

Denmark
Tufts Medical Center
Virginia Commonwealth University

Active, not recruiting

Effects of High Flow Nasal Cannula on Sputum Clearance in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease | COPD Exacerbation | Airflow Obstruction

United States
Zhujiang Hospital
Guangzhou Institute of Respiratory Disease

Unknown

Effects of Nutritional Supplementation in Malnourished Patients in Stable COPD

Malnutrition | Chronic Obstructive Pulmonary Disease(COPD)

China
AstraZeneca

Completed

A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers

Asthma, Chronic Obstructive Pulmonary Disease (COPD)

Germany
Aalborg University

Completed

Testing a Prediction Algorithm Into a Running Telehealth System for Patients With COPD

Chronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | COPD Exacerbation Acute

Denmark
Hospital de Cruces
Osakidetza; Basurto hospital; Euskal Herriko Unibertsitatea. Universidad del...

Unknown

Evaluation of Utility Quadriceps Magnetic Stimulation in COPD (Chronic Obstructive Pulmonary Disease) Patients After Hospital Exacerbation (COPD)

COPD | COPD Exacerbation

Spain
University of California, San Francisco
United States Department of Defense

Recruiting

Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers (Pre-COPD Pilot)

Smoking | Tobacco Use | Copd

United States
Mabwell (Shanghai) Bioscience Co., Ltd.

Recruiting

Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

China
Schön Klinik Berchtesgadener Land
GlaxoSmithKline GmbH & Co. KG (Munich, Germany); Coordinating Center for Clinical... and other collaborators

Active, not recruiting

Predictors of Acute Exacerbation in Patients With COPD - an Observational Study (PACE)

Chronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | COPD Exacerbation Acute

Germany
Aeris Therapeutics

Terminated

A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema

Lung Diseases | Pulmonary Emphysema | Chronic Obstructive Pulmonary Disease(COPD)

Israel
University Medical Center Groningen

Unknown

An Integrative Genomic Approach to Solve tHe Puzzle of sevERe earLy-Onset COPD (SHERLOCk)

Chronic Obstructive Pulmonary Disease | COPD | Severe Early-Onset COPD | SEO-COPD

Netherlands
University of Alabama at Birmingham

Completed

A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States
Asmacure Ltée

Completed

Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD)

COPD

Canada
Sunovion

Completed

Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States
AstraZeneca

Completed

Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (Columbus)

Moderate to Severe COPD

Sweden, Bulgaria, Poland, Denmark, Slovakia
AstraZeneca

Completed

A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment (KOSMOS)

COPD | Chronic Diseases

Denmark
Kırıkkale University

Recruiting

Evaluation in Elderly Individuals With Chronic Obstructive Pulmonary Disease(COPD)

COPD (Chronic Obstructive Pulmonary Disease)

Turkey
Fundación para la Investigación del Hospital Clínico...

Not yet recruiting

GOLD 0 - DLCO 1: A Look Beyond the Obstruction. Is Spirometry Enough for COPD (Chronic Obstructive Pulmonary Disease) Screening?

COPD, Chronic Obstructive Pulmonary Disease

Spain
Mylan Inc.
Theravance Biopharma

Completed

Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease, COPD

New Zealand
Astellas Pharma Global Development, Inc.
Cytokinetics

Completed

A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States
AstraZeneca
Parexel International Ltd; Cognizant Technology Solution; Center for Information... and other collaborators

Completed

Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (AERISTO)

Chronic Obstructive Pulmonary Disease COPD

United States, Canada, France, Russian Federation, Ukraine, Hungary, Bulgaria
University of Zurich
National Center of Cardiology and Internal Medicine named after academician...

Completed

Effect of Acetazolamide on Cognition in Patients With Respiratory Disease at Altitude

Chronic Obstructive Pulmonary Disease (COPD)

Kyrgyzstan
Novartis Pharmaceuticals

Completed

Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients (CLAIM)

Chronic Obstructive Pulmonary Disease, COPD

Germany
AstraZeneca
Quintiles, Inc.

Completed

Adherence Study in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD

United States
University of Leipzig
TNI Medical AG

Completed

Effectiveness of TNI vs. BiPAP in Chronic Global Insufficiency in COPD Patients (TIBICO)

COPD Chronic Obstructive Pulmonary Disease

Germany
Kazakhstan Academy of Preventive Medicine
Philip Morris International; Synergy Research Group Kazakhstan; HealthCity LLP

Completed

Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan

Chronic Obstructive Pulmonary Disease (COPD)

Kazakhstan
University of Ulster
KU Leuven; Belfast Health and Social Care Trust; Queen's University, Belfast; Western...

Completed

Physical Activity Versus Pulmonary Rehabilitation in COPD (LIVELY)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
AstraZeneca

Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)

Chronic Obstructive Pulmonary Disease (COPD)

France, Germany, United Kingdom, United States, Australia, Austria, Brazil, Hungary, New Zealand, Romania, Russian Federation
AstraZeneca

Completed

The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)

Chronic Obstructive Pulmonary Disease, COPD

France, Poland, South Africa, Spain, United States, Canada, United Kingdom
UPECLIN HC FM Botucatu Unesp
Faculdade de Medicina do ABC; IEP São Lucas - Instituto de Ensino e Pesquisa; Hemocentro São Lucas and other collaborators

Unknown

Cell Therapy in Advanced Chronic Obstructive Pulmonary Disease Patients

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
University of Southern Denmark
The Ministry of Science, Technology and Innovation, Denmark; Region of Southern...

Unknown

Prognosis and Treatment of COPD in Primary Care-use of Biomarkers (PROTECCT-M)

Chronic Obstructive Pulmonary Disease (COPD)

Denmark
Zhujiang Hospital
Guangzhou Institute of Respiratory Disease

Completed

Effects of CPAP Level on Respiratory Mechanics and Central Drive in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

China

3

Subscribe